Genmab — Maj 2018

[bibob]

God morgen.

[polle1]

God morgen

[Helge_LarsenPI-redaktør]

God morgen.

[E_L]

@Bulder @Solsen the same MIRROR article as a few weeks ago but with a bit more data http://n.neurology.org/content/90/20/e1805

[E_L]

This Nivolumab / BMS study now takes out Pomalidomide, Dexamethasone , Currently, this study is only open to nivolumab+daratumumab vs daratumumab monotherapy https://clinicaltrials.gov/ct2/history/NCT01592370?A=60&B=61&C=Side-by-Side

[E_L]

note that Janssen is now als involved in the study

[E_L]

Potential of VRD + Daratumumab in Myeloma - http://www.targetedonc.com/case-based-peer-perspectives/multiple-myeloma/chari-myeloma-treatment/potential-of-vrd-daratumumab-in-myeloma

[E_L]

actually this is a small serie of short videos, all interesting, just next to the video on the right

[E_L]

I find this very interesting "for example, when VMP was approved many years ago, oncologists took that to be able to use bortezomib frontline, but many people weren’t necessarily giving the melphalan with it" http://www.targetedonc.com/case-based-peer-perspectives/multiple-myeloma/chari-myeloma-treatment/use-of-vmp-daratumumab-in-myeloma

[E_L]

it is something that was suggested here in the chat earlier also (not sure if it was Bulder), can the US start using Dara/VMP frontline, but leave the melphalan out, or in lower dose...

[Bulder]

Yes, I asked Winkel about it. But he didn't comment. Nice to hear a doc, who is open to a modified combo-regimen. And he's very opposite to Rajkumar, who thought that D-VMp shouldn't have been aproved at all.

[Bulder]

And interesting what he is saying about early use of new combos before phase 3 data are ready. Bodes well for an early filing on the D-RVD phase 2 study.

[Bulder]

Is it today we expect warrants announcement?

[Bulder]

The above in English as it use to be E L who knows about these kind of things

[E_L]

today or tomorrow i would expect. It used to be on the Wednesday, last year it was on the Tuesday (and in Feb it was Wednesday again) #NerdFacts

[Her_for_at_lære]

@ Stockbull tak for dit svar. Jeg er skam investor. Men forsøger bare at forstå, udsvingne. Informationen om FDA godkendelsen er fra Syd Bank og deres oversigt https://data.sydbank.dk/api/investment/sydbank/publications/file/50139. Jeg melder mig naturligvis til Genmabs news. Tak og god dag

[Darvin]

AQR har da reduceret en smule :-). Heldigt for dem

[peter12]

Det kan vel tolkes som en opjustering

[peter12]

Dygtige ? Ikke deres short i Genmab da ..

[peter12]

De solgte desværre for mange i 1050,-...